Balyasny Asset Management LLC Akero Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$11.38 - $50.33 $1.81 Million - $8 Million
158,988 Added 404.72%
198,271 $4.63 Million
Q3 2023

Nov 14, 2023
SELL
$41.19 - $52.25 $1.58 Million - $2 Million
-38,250 Reduced 49.33%
39,283 $1.99 Million
Q2 2023

Aug 14, 2023
BUY
$36.89 - $56.88 $2.86 Million - $4.41 Million
77,533 New
77,533 $3.62 Million

Others Institutions Holding AKRO

# of Institutions
190
Shares Held
73.8M
Call Options Held
241K
Put Options Held
647K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.29B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email